On October 26 (local time), artificial intelligence company Anthropic officially filed for an initial public offering (IPO) with the U.S. Securities and Exchange Commission. The company plans to list on the Nasdaq Global Select Market under the ticker symbol “ANT.” This move makes Anthropic the first frontier AI lab to pursue a public market debut, potentially reaching Wall Street ahead of its rival, OpenAI.
The prospectus reveals explosive revenue growth for Anthropic: in the first half of 2026, revenue reached $16.29 billion—an increase of over 1,300% year-over-year. However, this rapid growth has come with heavy investment; the company reported a net loss of $80.7 billion for the same period, driven primarily by massive expenditures on computing infrastructure and changes in the fair value of financial instruments. Market observers estimate a target valuation between $1.5 trillion and $2 trillion—a range that, at the upper end, would surpass SpaceX to become the largest IPO in history.
Interestingly, just weeks ago, CEO Dario Amodei authored a piece calling for a slowdown in the development of the most advanced AI models, warning of potential existential risks. Yet, the risk disclosures in the prospectus are described by analysts as “fairly standard,” with no prominent mention of these specific concerns. By tapping into public capital markets, Anthropic is clearly securing “ammunition” for an intense AI arms race—even if doing so creates a subtle tension with the safety-focused stance previously championed by its founders. As the ticker “ANT” prepares for Wall Street’s valuation, the AI industry’s capital-fueled frenzy and its underlying safety concerns will both be thrust into the spotlight.
The article comes from the Internet. If there is any infringement, please notify me to delete it. Please indicate the source when reprinting！
If you have news to publish, please send it to:article@domain.news
